3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, T-Cell
4
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Anaplastic
2
Immunoblastic Lymphadenopathy
2
Subcutaneous panniculitis-like T-cell lymphoma
1
Mycosis Fungoides
1
Lymphoma, Follicular
1
Hematologic Neoplasms
1
Enteropathy-Associated T-Cell Lymphoma
1
Interventions
Paclitaxel
42
Carboplatin
37
Bevacizumab
29
liposomal doxorubicin
20
Taxes
18
Specimen Handling
18
pembrolizumab
16
olaparib
16
Magnetic Resonance Spectroscopy
16
Gemcitabine
16
Topotecan
13
Immunoglobulin G
12
Disulfides
12
Biopsy
11
niraparib
8
mirvetuximab soravtansine
8
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
10-propargyl-10-deazaaminopterin
×
1 year
×
Clear all
No trials found.